VivoSim Labs Statistics

Total Valuation

VivoSim Labs has a market cap or net worth of GBP 3.75 million. The enterprise value is -419,471.

Market Cap	3.75M
Enterprise Value	-419,471

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.78M
Shares Outstanding	n/a
Shares Change (YoY)	+90.82%
Shares Change (QoQ)	+4.04%
Owned by Insiders (%)	1.07%
Owned by Institutions (%)	8.59%
Float	2.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.03
PB Ratio	0.71
P/TBV Ratio	0.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.28
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.10, with a Debt / Equity ratio of 0.15.

Current Ratio	3.10
Quick Ratio	2.74
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-869.44

Financial Efficiency

Return on equity (ROE) is -36.91% and return on invested capital (ROIC) is -117.31%.

Return on Equity (ROE)	-36.91%
Return on Assets (ROA)	-92.55%
Return on Invested Capital (ROIC)	-117.31%
Return on Capital Employed (ROCE)	-168.19%
Revenue Per Employee	8,012
Profits Per Employee	-113,479
Employee Count	13
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

In the past 12 months, VivoSim Labs has paid 1,488 in taxes.

Income Tax	1,488
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.86% in the last 52 weeks. The beta is 1.13, so VivoSim Labs's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	-74.86%
50-Day Moving Average	5.35
200-Day Moving Average	10.99
Relative Strength Index (RSI)	38.65
Average Volume (20 Days)	9,214

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.08

Income Statement

In the last 12 months, VivoSim Labs had revenue of GBP 104,152 and -1.48 million in losses. Loss per share was -0.72.

Revenue	104,152
Gross Profit	-3.29M
Operating Income	-9.06M
Pretax Income	-1.47M
Net Income	-1.48M
EBITDA	-8.87M
EBIT	-9.06M
Loss Per Share	-0.72

Full Income Statement

Balance Sheet

The company has 4.97 million in cash and 782,625 in debt, giving a net cash position of 4.18 million.

Cash & Cash Equivalents	4.97M
Total Debt	782,625
Net Cash	4.18M
Net Cash Per Share	n/a
Equity (Book Value)	5.26M
Book Value Per Share	2.02
Working Capital	3.83M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.55M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-8,694.25%
Pretax Margin	-1,414.99%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VivoSim Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-90.82%
Shareholder Yield	-90.82%
Earnings Yield	-39.31%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 19, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Aug 19, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

VivoSim Labs has an Altman Z-Score of -52.4 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-52.4
Piotroski F-Score	3